Brain Glioma Causes
Brain Glioma Causes
For most people with a glioma, no cause will be identified, and that is the honest starting point. The one environmental factor that is established is exposure to ionising radiation at therapeutic doses — the kind given as treatment, not the kind received from a diagnostic scan. A small proportion of gliomas occur in people with an inherited syndrome, and these are recognisable because of the other features of the syndrome or the family history. Everything else that is commonly blamed — mobile phones, head injury, diet, stress — has been studied and not supported.
Ionising radiation
Radiation is the only environmental exposure for which the evidence is established, and being precise about the dose matters because the word covers very different things:
- Therapeutic doses are the relevant exposure. The association comes from people who received radiotherapy to the head, particularly in childhood, and from studies of populations exposed to high doses. The risk rises with the dose received.
- Diagnostic imaging has not been shown to cause glioma. CT and X-ray examinations use far lower doses, and no study has established them as a cause. This is a reason not to fear a necessary scan, and equally a reason not to request unnecessary ones.
- Radiation-induced tumours appear after a long interval — typically many years — which is one reason the association is difficult to study and why it is relevant mainly to people treated with radiotherapy long ago.
- What follows for a patient — if you had radiotherapy to the head in the past, mention it, but it does not change the treatment of a glioma now, and it does not imply anything about your family.
Inherited syndromes
A minority of gliomas occur in people with an inherited condition. These are worth knowing about because, unlike most risk factors, they lead to defined surveillance rather than to general advice:
- Neurofibromatosis type 1 — associated with gliomas of the optic pathway and elsewhere, usually in childhood, and with other features that are recognisable clinically.
- Neurofibromatosis type 2 — associated with ependymoma as well as with schwannoma and meningioma, and with a defined imaging surveillance programme.
- Li-Fraumeni syndrome — caused by an inherited TP53 alteration, associated with several tumour types including glioma at a younger age than usual.
- Lynch syndrome and constitutional mismatch repair deficiency — associated with glioma alongside bowel and other cancers, the latter particularly in childhood.
- Tuberous sclerosis complex — associated with a particular tumour type arising near the fluid spaces, for which surveillance and sometimes targeted treatment are established.
- What these mean practically — if you have one of these diagnoses, surveillance is already defined and should be followed; if a syndrome is suspected because of other features or a strong family history, referral for genetic assessment is appropriate.
Age, sex and population patterns
The patterns in who develops a glioma are consistent across registries, and worth stating plainly because they are often read as more than they are:
- Age works in opposite directions by type. Glioblastoma occurs mainly in older adults, while the slower-growing diffuse gliomas are typically diagnosed in younger adults, often in their thirties and forties.
- Children have their own gliomas. Paediatric gliomas are biologically distinct, with different molecular drivers and different treatment, which is why they are not managed as adult tumours in miniature.
- Sex — male is slightly more often affected than female, for reasons that are not established.
- Population patterns — recorded incidence differs between regions, with higher rates reported in some countries than others; differences in how thoroughly cases are registered and diagnosed contribute to this, so the figures should be read cautiously.
- None of these identifies a cause, and none of them changes what treatment is given.
Factors that do not cause glioma
Patients and families usually arrive with a specific worry about what they might have done. For the factors below, the evidence does not support a causal role, and saying so precisely is part of an honest answer:
- Mobile phones — studied extensively, including in large coordinated international projects, without a consistent increase in risk being found. It remains one of the most common questions and one of the most thoroughly examined negative findings.
- Head injury — not established as a cause. A scan done after an injury may reveal a tumour that was already there, which is why the two become linked in people's minds.
- Smoking — an established cause of many cancers, but not of glioma. This is unusual enough to be worth stating rather than folding into general advice.
- Diet and alcohol — no dietary pattern or food has been shown to cause glioma.
- Stress, personality and emotional circumstances — no evidence of a causal role. Suggesting otherwise places blame where none belongs.
- Power lines and electromagnetic fields — studied repeatedly and not confirmed as a cause.
Family history
Because a brain tumour is a frightening diagnosis, families often ask whether they or their children are at risk. The answer is usually reassuring, with one qualification:
- Most gliomas occur in people with no affected relative and no identifiable inherited condition.
- A family history does modestly increase risk, particularly where a close relative was diagnosed at a young age or where more than one relative is affected.
- A recognisable pattern suggests a syndrome — several different tumour types appearing across generations, cancer at unusually young ages, or known features of one of the conditions described above — and in that case genetic assessment is appropriate.
- No imaging-based screening is recommended for relatives of an ordinary patient, because the risk is small and no benefit from early detection has been demonstrated.
- What to do with the information — mention the family history at any assessment, and ask directly whether genetic referral is warranted in your family. For most families the answer is no, and that answer is worth hearing explicitly.
Who is at higher risk, and who is not
Risk in glioma is a matter of degree rather than of presence or absence, and the distinction determines what should actually be done:
- Higher risk, with defined surveillance — people with an inherited syndrome such as neurofibromatosis type 1 or 2, Li-Fraumeni syndrome, Lynch syndrome or tuberous sclerosis complex. For these groups, scheduled imaging is already part of care and should be followed.
- Modestly higher risk — a history of therapeutic radiotherapy to the head, a first-degree relative with a glioma, and increasing age for the aggressive forms.
- Not at measurably higher risk — people with none of those features, which is the great majority of adults.
- What the difference means in practice — for the first two groups there is either surveillance or a reason for attention to symptoms; for everyone else there is no recommended testing, and the reasonable approach is to have a new seizure, a progressive neurological deficit or a persistent headache with vomiting assessed rather than assumed.
- What is not useful — routine scanning without a reason, or treating a common symptom as though it were a tumour. Both cause harm, and neither is recommended.